Trial intelligence / Profile preview

Patient Preference Comparison of Azarga versus Cosopt in Open-angle Glaucoma or Ocular Hypertension

2009-015796-27Phase 4Completed

Sponsor
Alcon Inc.
Start
Sep 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, randomised trial of brinzolamide and dorzolamide in open-angle glaucoma (OAG) and ocular hypertension (2 arms), sponsored by Alcon Inc. Primary endpoint: Patient preference for Azarga vs Cosopt based on ocular comfort. Started Sep 2009; status: completed.

02

Drugs

brinzolamidedorzolamide
03

Conditions

open-angle glaucoma (OAG)ocular hypertension

Beyond the preview

Go deeper on 2009-015796-27.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2009-015796-27.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call